Sacubitril and Valsartan-Reference product
Sponsors
Bio-innova Co., Ltd, Humanis Saglık Anonim Sirketi
Conditions
Chronic Heart FailureHealthy Subjects
Phase 1
Sacubitril 97 mg and Valsartan 103 mg Film-coated Tablets Relative to Entresto 97 mg/103 mg Film-coated Tablets
Not yet recruitingNCT06248112
Start: 2024-05-06End: 2024-07-06Target: 40Updated: 2024-02-08
Bioequivalence Study to Compare Sacubitril and Valsartan Tablets (97mg/103mg) Versus Entresto® (Sacubitril and Valsartan) Tablets (97 mg/103 mg)
CompletedNCT06922253
Start: 2024-12-28End: 2025-03-17Updated: 2025-04-10